logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
21/06/2025
Futai Pharmaceutical (VRTX) presents positive data for Zimislecel (VX-880), a stem cell therapy for type 1 diabetes.
Latest
3 m ago
Institution: In June, there was a slight downward trend in the prices of television panels.
4 m ago
Shaanxi Comprehensive Bonded Zone held a special investment promotion event for Tianjin and Hebei provinces. Five companies have expressed their intention to invest in Shaanxi and cooperate.
5 m ago
Trinity Group signs strategic cooperation agreement with ZF.
5 m ago
This week, three stocks including Ningbo Huaxiang, Shengnuo Biology, and Obi Zhongguang have released performance forecasts, among which one stock is expected to significantly increase its performance. Shengnuo Biology's net profit is forecasted to increase by 332.1% year-on-year.
6 m ago
Mobile Home publicly apologizes to Xiaomi.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.